Herpes zoster and postherpetic neuralgia in Catalonia (Spain)

References

• Salleras L, Domínguez A, Plans P, Costa J, Cardeñosa N, Torner N, Plasència A. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol 2008; 197:329 - 33; http://dx.doi.org/10.1007/s00430-007-0064-z; PMID: 18004592
   PubMed Web of Science ®Google Scholar
• Salleras L, Domínguez A, Vidal J, Plans P, Salleras M, Taberner JL. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine 2000; 19:183 - 8; http://dx.doi.org/10.1016/S0264-410X(00)00178-X; PMID: 10930671
   PubMedGoogle Scholar
• Dworkin RH, Schmader KE. Epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, eds. Herpes zoster and postherpetic neuralgia, 2nd ed. New York: Elsevier Press, 2001:39-64.
   Google Scholar
• Salleras L, Salleras M, Prat M, Garrido P, Domínguez A.. Vacunas frente al virus de la varicela zoster. Enferm Infecc Microbiol Clin 2007; 25:Supl. 4 29 - 47
   Google Scholar
• Holodniy M. Prevention of shingles by varicella zoster virus vaccination. Expert Rev Vaccines 2006; 5:431 - 43; http://dx.doi.org/10.1586/14760584.5.4.431; PMID: 16989624
   PubMed Web of Science ®Google Scholar
• Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352:2266 - 7; http://dx.doi.org/10.1056/NEJMp058091; PMID: 15930416
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341 - 9; http://dx.doi.org/10.4065/82.11.1341; PMID: 17976353
   PubMed Web of Science ®Google Scholar
• Johnson R, McElhaney J, Pedalino B, Levin M. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis 2007; 11:Suppl 2 S43 - 8; http://dx.doi.org/10.1016/S1201-9712(07)60021-6; PMID: 18162246
   PubMed Web of Science ®Google Scholar
• Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M. Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother 2013; 9:1177 - 84; http://dx.doi.org/10.4161/hv.23491; PMID: 23324598
   PubMed Web of Science ®Google Scholar
• Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ 2010; 182:1731 - 6; http://dx.doi.org/10.1503/cmaj.091711; PMID: 20921251
   PubMed Web of Science ®Google Scholar
• Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, Chan IS, Choo P, Levin MJ, Johnson G, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007; 23:490 - 6; http://dx.doi.org/10.1097/AJP.0b013e318065b6c9; PMID: 17575488
   PubMed Web of Science ®Google Scholar
• Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37; http://dx.doi.org/10.1186/1741-7015-8-37; PMID: 20565946
   PubMed Web of Science ®Google Scholar
• White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM, Segraves AW. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 2009; 27:781 - 92; http://dx.doi.org/10.2165/11317560-000000000-00000; PMID: 19757871
   PubMed Web of Science ®Google Scholar
• Cebrián-Cuenca AM, Díez-Domingo J, Rodríguez MS, Puig-Barberá J, Navarro-Pérez J, Herpes Zoster Research Group of the Valencian Community. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract 2010; 11:33; http://dx.doi.org/10.1186/1471-2296-11-33; PMID: 20459608
   PubMed Web of Science ®Google Scholar
• Cebrián-Cuenca AM, Díez-Domingo J, San-Martín-Rodríguez M, Puig-Barberá J, Navarro-Pérez J, Herpes Zoster Research Group of the Valencian Community. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis 2011; 11:302; http://dx.doi.org/10.1186/1471-2334-11-302; PMID: 22044665
   PubMed Web of Science ®Google Scholar
• Morant-Talamante N, Diez-Domingo J, Martínez-Úbeda S, Puig-Barberá J, Alemán-Sánchez S, Pérez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis 2013; 13:463; http://dx.doi.org/10.1186/1471-2334-13-463; PMID: 24094135
   PubMed Web of Science ®Google Scholar
• Pérez-Farinós N, Ordobás M, García-Fernández C, García-Comas L, Cañellas S, Rodero I, Gutiérrez-Rodríguez A, García-Gutiérrez J, Ramírez R. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004. BMC Infect Dis 2007; 7:59; http://dx.doi.org/10.1186/1471-2334-7-59; PMID: 17570859
   PubMed Web of Science ®Google Scholar
• Esteban-Vasallo MD, Gil-Prieto R, Domínguez-Berjón MF, Astray-Mochales J, Gil de Miguel A. Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005-2012. J Infect 2014; 68:378 - 86; http://dx.doi.org/10.1016/j.jinf.2013.09.035; PMID: 24247069
   PubMed Web of Science ®Google Scholar
• García Cenoz M, Castilla J, Montes Y, Morán J, Salaberri A, Elía F, Floristán Y, Rodrígo I, Irisarri F, Arriazu M, et al. Incidencia de la varicela y el herpes zóster antes de la introducción de la vacunación sistemática infantil en Navarra, 2005-2006. An Sist Sanit Navar 2008; 31:71 - 80; http://dx.doi.org/10.4321/S1137-66272008000100006; PMID: 18496581
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al, Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271 - 84; http://dx.doi.org/10.1056/NEJMoa051016; PMID: 15930418
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57:RR-5 1 - 30, quiz CE2-4; PMID: 18528318
   PubMedGoogle Scholar
• Salleras L, Salleras M. Vacunación frente al herpes zoster. Vacunas 2014; In press
   Google Scholar
• Schmader KE, Levin MJ, Gnann JW Jr., McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54:922 - 8; http://dx.doi.org/10.1093/cid/cir970; PMID: 22291101
   PubMed Web of Science ®Google Scholar
• Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013; 13:170; http://dx.doi.org/10.1186/1471-2334-13-170; PMID: 23574765
   PubMed Web of Science ®Google Scholar
• Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of Herpes Zoster: a prospective population based study. Vaccine 2006; 24:1308 - 14; http://dx.doi.org/10.1016/j.vaccine.2005.09.026; PMID: 16352376
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137:38 - 47; http://dx.doi.org/10.1017/S0950268808000678; PMID: 18466661
   PubMed Web of Science ®Google Scholar
• Parruti G, Tontodonati M, Rebuzzi C, Polilli E, Sozio F, Consorte A, Agostinone A, Di Masi F, Congedo G, D’Antonio D, et al, VZV Pain Study Group. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med 2010; 8:58 - 68; http://dx.doi.org/10.1186/1741-7015-8-58; PMID: 20937086
   PubMedGoogle Scholar
• Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 2001; 19:3076 - 90; http://dx.doi.org/10.1016/S0264-410X(01)00044-5; PMID: 11312002
   PubMed Web of Science ®Google Scholar
• Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplège A, El Hasnaoui A, de Labareyre C. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62 - 9; http://dx.doi.org/10.1086/320884; PMID: 11389496
   PubMed Web of Science ®Google Scholar
• Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of Herpes Zoster and its complications. J Infect 2013; 67:463 - 9; http://dx.doi.org/10.1016/j.jinf.2013.06.016; PMID: 23872209
   PubMed Web of Science ®Google Scholar
• Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc 2009; 84:787 - 94; http://dx.doi.org/10.4065/84.9.787; PMID: 19720776
   PubMed Web of Science ®Google Scholar
• Boletín Oficial del Consejo General del Colegio de Farmacéuticos de España. February 2012
   Google Scholar
• DOGC 6079. Ordre SLT/42/2012, de 24 de febrer, per la qual es regulen els supòsits i conceptes facturables i s’aproven els preus públics corresponents als serveis que presta l’Institut Català de la Salut.
   Google Scholar